SPY Angiography To Assist With Ulnar Nerve Transposition at the Elbow

• Status: Not yet recruiting
• Trial end date: 2024-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients with vascular disease, thyroid disease or an allergy to indocyanine green (ICG) will be excluded. Patients with either median or ulnar nerve compression will be treated with nerve decompression. SPY angiography will be used to assess the vascularity of the nerve both pre and post release as the primary outcome measure.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: NYU Langone Health

Criteria

Inclusion Criteria:

• 18 years old or older; male and female patients

• Ulnar Nerve Compression at the Elbow

• Failed conservative treatment (i.e. hand therapy, pain medications, splinting)

• Able to provide informed consent

Exclusion Criteria:

• Pregnancy/breastfeeding

• Thyroid Disease

• Vascular Disease

• Known allergy to any study drug